527 related articles for article (PubMed ID: 32679539)
1. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
Zhong Y; Li YP; Yin YQ; Hu BL; Gao H
Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.
Wang L; Liu J; Wang Z; Qian X; Zhao Y; Wang Q; Dai N; Xie Y; Zeng W; Yang W; Bai X; Yang Y; Qian J
Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462
[TBL] [Abstract][Full Text] [Related]
3. Sevoflurane exerts protection against myocardial ischemia-reperfusion injury and pyroptosis through the circular RNA PAN3/microRNA-29b-3p/stromal cell-derived factor 4 axis.
An L; Zhong Y; Tan J; Liu Y; Li A; Yang T; Wang S; Liu Y; Gao H
Int Immunopharmacol; 2023 Jul; 120():110219. PubMed ID: 37270931
[TBL] [Abstract][Full Text] [Related]
4. MiR-155 is Involved in Renal Ischemia-Reperfusion Injury via Direct Targeting of FoxO3a and Regulating Renal Tubular Cell Pyroptosis.
Wu H; Huang T; Ying L; Han C; Li D; Xu Y; Zhang M; Mou S; Dong Z
Cell Physiol Biochem; 2016; 40(6):1692-1705. PubMed ID: 28006785
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of lncRNA HULC Attenuates Myocardial Ischemia/reperfusion Injury in Rat Models and Apoptosis of Hypoxia/reoxygenation Cardiomyocytes via Targeting miR-377-5p through NLRP3/Caspase‑1/IL‑1β Signaling Pathway Inhibition.
Liang H; Li F; Li H; Wang R; Du M
Immunol Invest; 2021 Nov; 50(8):925-938. PubMed ID: 32674625
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting MicroRNA-29a Protects Myocardial Ischemia-Reperfusion Injury by Targeting SIRT1 and Suppressing Oxidative Stress and NLRP3-Mediated Pyroptosis Pathway.
Ding S; Liu D; Wang L; Wang G; Zhu Y
J Pharmacol Exp Ther; 2020 Jan; 372(1):128-135. PubMed ID: 31481517
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling.
Yang FY; Zhang L; Zheng Y; Dong H
Bioengineered; 2022 Jan; 13(1):1377-1387. PubMed ID: 34974801
[TBL] [Abstract][Full Text] [Related]
8. Propofol protects cardiomyocytes from hypoxia/reoxygenation injury via regulating MALAT1/miR-206/ATG3 axis.
Jing H; Wang C; Zhao L; Cheng J; Qin P; Lin H
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22880. PubMed ID: 34383354
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine alleviates myocardial ischemia-reperfusion injury by down-regulating miR-34b-3p to activate the Jagged1/Notch signaling pathway.
Guo P; Yi H; Han M; Liu X; Chen K; Qing J; Yang F
Int Immunopharmacol; 2023 Mar; 116():109766. PubMed ID: 36764271
[TBL] [Abstract][Full Text] [Related]
10. Melatonin Inhibits OGD/R-Induced H9c2 Cardiomyocyte Pyroptosis via Regulation of MT2/miR-155/FOXO3a/ARC Axis.
Chen R; Yang M
Int Heart J; 2022; 63(2):327-337. PubMed ID: 35354753
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca
Zheng X; Li J; Fan Q; Zhao X; Chen K
Int J Cardiol; 2021 Sep; 338():185-195. PubMed ID: 33731281
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
[TBL] [Abstract][Full Text] [Related]
13. Stem cell-derived exosomes prevent pyroptosis and repair ischemic muscle injury through a novel exosome/circHIPK3/ FOXO3a pathway.
Yan B; Zhang Y; Liang C; Liu B; Ding F; Wang Y; Zhu B; Zhao R; Yu XY; Li Y
Theranostics; 2020; 10(15):6728-6742. PubMed ID: 32550900
[No Abstract] [Full Text] [Related]
14. Dexmedetomidine post-treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF-1α signalling.
Peng K; Chen WR; Xia F; Liu H; Meng XW; Zhang J; Liu HY; Xia ZY; Ji FH
J Cell Mol Med; 2020 Jan; 24(1):850-861. PubMed ID: 31680420
[TBL] [Abstract][Full Text] [Related]
15. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
Zhang J; Jiang H; Liu DH; Wang GN
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
[TBL] [Abstract][Full Text] [Related]
16. Up-regulating microRNA-138-5p enhances the protective role of dexmedetomidine on myocardial ischemia-reperfusion injury mice via down-regulating Ltb4r1.
Chang Y; Xing L; Zhou W; Zhang W
Cell Cycle; 2021 Feb; 20(4):445-458. PubMed ID: 33509010
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of microRNA-327 ameliorates ischemia/reperfusion injury-induced cardiomyocytes apoptosis through targeting apoptosis repressor with caspase recruitment domain.
Li Q; Yang J; Zhang J; Liu XW; Yang CJ; Fan ZX; Wang HB; Yang Y; Zheng T; Yang J
J Cell Physiol; 2020 Apr; 235(4):3753-3767. PubMed ID: 31587299
[TBL] [Abstract][Full Text] [Related]
18. LOXL1-AS1 Aggravates Myocardial Ischemia/Reperfusion Injury Through the miR-761/PTEN Axis.
He W; Duan L; Zhang L
Korean Circ J; 2023 Jun; 53(6):387-403. PubMed ID: 37161797
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine alleviates pulmonary ischemia-reperfusion injury through modulating the miR-21-5p/Nr4a1 signaling pathway.
Dong W; Yang H; Cheng M; Zhang X; Yin J; Zeng Z; Huang G
Acta Biochim Pol; 2020 Dec; 67(4):521-529. PubMed ID: 33332077
[TBL] [Abstract][Full Text] [Related]
20. MiR-139 protects against oxygen-glucose deprivation/reoxygenation (OGD/R)-induced nerve injury through targeting c-Jun to inhibit NLRP3 inflammasome activation.
Wang QS; Luo XY; Fu H; Luo Q; Wang MQ; Zou DY
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105037. PubMed ID: 32807449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
